☰ Accessibility

UTI Asset Management Company Limited (UTI AMC) has enhanced employee participation in the company by approving the allotment of 22,732 equity shares under its Employee Stock Option Scheme (ESOS) 2007. The move reflects the firm’s ongoing efforts to strengthen employee engagement and align long-term interests between staff and shareholders.

Key Details of the Allotment

Aspect Details
Number of Shares Allotted 22,732
Face Value per Share ₹10.00
Date of Approval November 12, 2025
Scheme Name UTI AMC Employee Stock Option Scheme – 2007

Impact on Share Capital

Following this allotment, UTI AMC’s issued and paid-up capital has increased from ₹1,28,27,53,540 to ₹1,28,29,80,860, while the total number of equity shares has risen from 12,82,75,354 to 12,82,98,086.

Metric Before Allotment After Allotment
Issued & Paid-up Capital ₹1,28,27,53,540 ₹1,28,29,80,860
Total Equity Shares 12,82,75,354 12,82,98,086

Implications for Shareholders

The newly issued shares will carry equal rights and privileges as the existing shares, including voting rights, dividend eligibility, and other entitlements under the Articles of Association.

This move underscores UTI AMC’s commitment to fostering a performance-driven culture and rewarding long-term value creation among employees.

Summary

UTI AMC has allotted 22,732 equity shares under its ESOS 2007, increasing its total paid-up capital to ₹1,28,29,80,860. The allotment aims to promote employee ownership, aligning workforce incentives with shareholder value while maintaining uniform rights across all equity shares.

Disclaimer:

This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.

Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.